Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264585 | 0.84 | CA12 (0.52) | ALDH1A1CYP2D6NOS1HDAC3HDAC4 | |
| SCHEMBL27918265 | 0.76 | NOS1 (0.47) | CYP2D6NOS1HDAC3HDAC4HDAC1 | |
| SCHEMBL556967 | 0.74 | ALDH1A1 (0.54) | ALDH1A1CYP2D6HDAC3HDAC4HDAC1 | |
| SCHEMBL8202595 | 0.74 | NOS1 (0.57) | ALDH1A1CYP2D6NOS1HDAC3HDAC4 | |
| SCHEMBL3290109 | 0.74 | HDAC3 (0.58) | ALDH1A1CYP2D6NOS1HDAC3HDAC4 | |
| SCHEMBL27352286 | 0.74 | L3MBTL1 (0.50) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28248357 | 0.74 | CA12 (0.41) | ALDH1A1CYP2D6HDAC3HDAC4HDAC1 | |
| SCHEMBL9849714 | 0.73 | ALDH1A1 (0.47) | ALDH1A1CYP2D6NOS1HDAC3HDAC4 | |
| SCHEMBL7370964 | 0.72 | SMN1; SMN2 (0.50) | ALDH1A1CYP2D6SMN1; SMN2MAPTKMT2A | |
| SCHEMBL22182883 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025053156-A1 | COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) SEGMENT AND REPEATING UNIT HAVING N-ACYLETHANOLAMINE OR HOMOLOGUE OR ANALOG THEREOF IN SIDE CHAIN, NANOPARTICLES OF SAID COPOLYMER, AND USE THEREOF | 国立大学法人筑波大学 | 2025-03-13 | — | — | WO | disclosed |
| CN-110997882-B | Lubricating composition containing self-assembled polymethacrylate block copolymer and ethylene-alpha-olefin copolymer | 路博润公司 | 2023-08-08 | — | — | CN | disclosed |
| WO-2015192175-A1 | POLYMER HYDROGEL | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-23 | — | — | WO | disclosed |
| CN-101918122-A | Graft copolymer and composition thereof | LUBRIZOL LTD | 2010-12-15 | — | — | CN | disclosed |
| EP-1673662-A1 | LOW-POLYDISPERSITY PHOTOIMAGEABLE POLYMERS AND PHOTORESISTS AND PROCESSES FOR MICROLITHOGRAPHY | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-06-28 | — | — | EP | disclosed |
| US-20060094880-A9 | Synthetic process for trans-aminocyclohexyl ether compounds | BARRETT ANTHONY G M | 2006-05-04 | — | — | US | disclosed |
| WO-2005031462-A1 | LOW-POLYDISPERSITY PHOTOIMAGEABLE POLYMERS AND PHOTORESISTS AND PROCESSES FOR MICROLITHOGRAPHY | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-04-07 | — | — | WO | disclosed |
| US-20050038256-A1 | Synthetic process for trans-aminocyclohexyl ether compounds | CARDIOME PHARMA CORP. (CA) | 2005-02-17 | — | — | US | disclosed |
| EP-1054906-A1 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999031144-A1 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094880-A9 | Synthetic process for trans-aminocyclohexyl ether compounds | AKR1C3, CBR1, CBR3 | ALDH1A1 1484/4885CYP2D6 88/4885NOS1 990/4885 |
| US-20050038256-A1 | Synthetic process for trans-aminocyclohexyl ether compounds | AKR1C3, CBR1, CBR3 | ALDH1A1 1484/4885CYP2D6 88/4885NOS1 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.